Page 4 - Ea Scan News Today

An exhibit in France presents the artists anatomic studies and shows how he anticipated the images produced by CT and MRI.

In a phase 3 trial, the monoclonal antibody donanemab slowed clinical and functional decline by 35% for patients with early Alzheimers disease. However, the drug was not without safety issues.

Measuring the thickness of the retina shortly after diagnosis in multiple sclerosis patients could predict their risk of accumulated disability later in the disease course, say Austrian researchers.

New research criteria appear to accurately identify athletes in sports such as boxing or martial arts who will go on to develop chronic traumatic encephalopathy.

The Elecsys beta-amyloid (1-42) and Elecsys total-tau CSF assays (used as a tTau/Abeta42 ratio) are for use in adults ages 55 and older being evaluated for cognitive issues.

A new study and a meta-analysis provide more evidence that patients with large ischemic strokes and a significant amount of brain tissue damage may still benefit from thrombectomy.

Both coronary plaque burden and the rate of plaque progression are increased in patients with high Lp(a) levels, potentially explaining the link with higher CV risk, new findings suggest.

Previous research has found that life stressors are linked to clinical MS flares.

Prophylactic use of antiemetic, antipyretic, or antibiotic drugs in older patients with acute stroke did not reduce the risk of a poor functional outcome in the PRECIOUS trial.

A qualitative study found that a British Columbia-based safer supply program that uses biometric machines reduced overdose risks and illicit drug use.